2022 Course Highlights




  • Is Grandma really using fentanyl? Pitfalls in interpreting toxicology screens
  • What’s new in street drugs
  • New FDA guidelines for using naloxone
  • Treating acute and chronic pain in patients with substance use disorder
  • Phenobarbital in the management of alcohol withdrawal
  • Reducing the risk of recurrent opiate overdose at discharge



  • What to do when there is no allergist
  • Getting rid of the low-risk penicillin allergy label
  • New anaphylaxis guidelines
  • Class action: sorting out the overlap between penicillin and cephalosporins
  • Things we do for no reason: steroids for anaphylaxis? 



  • Dual anti-platelet therapy after stenting: are we overdoing it?
  • Rethinking rhythm control versus rate control for atrial fibrillation
  • Peri-operative anticoagulation in patients on DOACs
  • Post-op atrial fibrillation: to anticoagulate, or not to anticoagulate?
  • SGLT-2 inhibitors: a new standard for CHF treatment
  • How low should you go? Hemoglobin targets in acute coronary syndromes
  • Reducing readmissions for heart failure: best practices in discharge planning
  • Overcoming diuretic resistance in heart failure
  • Is it ever OK to stop anticoagulation in unprovoked venous thrombosis?
  • When to refer patients with aortic stenosis for TAVR



  • Update on pharmacotherapy for delirium
  • Reducing delirium complications: is a bedside companion key?
  • Hospital-acquired delirium: a risk factor for dementia
  • Difficult cases in delirium management



  • Can't-miss ECG diagnoses
  • Radiology pearls: identifying subtle findings on CXR
  • Rapid-fire review of electrolyte, liver, and heme cases
  • Contrast or no contrast? Choosing the right imaging protocols



  • Dangers of SGLT2 inhibitors: euglycemic DKA and UTIs
  • Challenging cases in insulin management
  • Best practices for hyperglycemic crises
  • New treatments for diabetes and their role in hospital medicine



  • Removing race from hospital laboratory calculators and reference ranges
  • Anti-racism in hospital medicine
  • Improving access to liver transplantation



  • New guidelines for ascites and spontaneous bacterial peritonitis
  • Referral practices for NAFLD/NASH
  • New guidelines on management of upper and lower GI bleeds
  • Optimal timing for intra-abdominal drainage in necrotizing pancreatitis
  • Time to rethink the "GI cocktail?"
  • Urgent endoscopy in acute GI bleeding: bad for patients?
  • Managing the cirrhotic patient with bleeding and thrombosis
  • Too soon? When to resume anticoagulation and antiplatelet agents after a GI bleed



  • DOACs for cancer-associated venous thrombosis
  • DOAC use in obesity and kidney disease
  • Diagnosing and managing thrombocytopenia
  • Approach to anemia in the hospitalized patient
  • The latest on COVID-associated thrombosis
  • New venous thromboembolism guidelines



  • Short-course antibiotics for common infections
  • New antibiotics for MRSA and multidrug-resistant gram-negative rods
  • Monkeypox: how worried should we be?
  • When are oral drugs appropriate for bacteremia?
  • MRSA bacteremia: is vancomycin enough?
  • SARS-CoV-2: the latest on vaccines and variants
  • New oral drugs for COVID
  • Monoclonal antibodies for COVID-19: do they work against variants?
  • Intensive case-based review of inpatient antibiotic therapy
  • New antibiotics for complicated UTIs
  • Pearls for interpreting culture and sensitivity data



  • Palliative care in end-stage dementia
  • Alternatives to the 10-point pain scale
  • Case-based approach to the complex palliative care patient
  • What time is the right time to call palliative care?



  • The latest on perioperative aspirin, statins, beta blockers, and ACE inhibitors
  • Perioperative anticoagulation: when should patients be bridged?
  • Timing of surgery in hip fracture patients
  • Reducing pulmonary risk in perioperative patients
  • The role of biomarkers in preoperative management



  • Tailored steroid therapy in acute exacerbation of COPD
  • New asthma guidelines: is albuterol still appropriate for rescue therapy?
  • State-of-the-art treatment for asthma and COPD exacerbations
  • Current recommendations for high-flow and supplemental O2
  • New Surviving Sepsis guidelines



  • Dapagliflozin and reduction of progression of chronic kidney disease
  • New data: early renal replacement therapy in acute kidney injury
  • COVID and acute kidney injury: what the hospitalist needs to know
  • Dialysis access: what the hospitalist needs to know
  • A salty dispute: LR vs NS revisited
  • Diagnosing the patient with acute glomerulonephritis
  • Blood pressure management in end-stage renal disease
  • The latest on managing hyperkalemia and hyperphosphatemia
  • Diagnosing acute kidney injury and acute glomerulonephritis



  • New AHA/ASA guidelines for stroke management
  • Updates on mechanical thrombectomy for ischemic stroke
  • Telestroke: an idea whose time has come?
  • Anti-platelet therapy in stroke and TIA
  • How long should we monitor for atrial fibrillation after stroke?



  • Syncope: when to worry about cardiac causes
  • New recommendations for the use of tilt table testing
  • Syncope as a presenting symptom of COVID
  • Diagnosing the patient with recurrent syncope
  • Midodrine for vasovagal syncope?